1.86
1.86 (0%)
As of Feb 14, 2025
Ispecimen Inc. [ISPC]
Source:
Company Overview
iSpecimen is technology-driven company founded to address a critical challenge: how to connect life science researchers who need human for their research, with the billions of biospecimens available (but not easily accessible) in healthcare provider organizations worldwide. Our ground-breaking iSpecimen Marketplace platform was designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery.
| Country | United States |
| Headquarters | lexington, massachusetts |
| Phone Number | 781-301-6700 |
| Industry | services |
| CEO | Tracy Curley |
| Website | www.ispecimen.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $2.7 |
| Operating Profit | $-1.7 |
| Net Income | $-1.4 |
| Net Cash | $-0.6 |
Profit Ratios
| Gross Margin | $1.1 |
| Operating Margin | -64.1 |
| Profit as % of Revenues | -76.9% |
| Profit as % of Assets | -20.7% |
| Profit as % of Stockholder Equity | -30.5% |
Management Effectiveness
| Return on Equity | -30.5% |
| Return on Assets | -12.8% |
| Turnover Ratio | 38.2% |
| EBITA | $-1.7 |
Balance Sheet and Cash Flow Measures
| Total Assets | $11.3 |
| Total Liabilities | $6.5 |
| Operating Cash Flow | $-4.7 |
| Investing Cash Flow | $2.1 |
| Financing Cash Flow | $2 |
